MedPath

Predictive factors associated with in-hospital mortality in acute myeloid leukemia patients after induction chemotherapy

Completed
Conditions
Acute myeloid leukemia patients admitted for induction chemotherapy treatment.
acute myeloid leukemia, predictor, mortality, chemotherapy
Registration Number
TCTR20240810001
Lead Sponsor
/A
Brief Summary

19 patients (21%) died during the hospitalization within 30 days after chemotherapy. The leading cause of death (89%) was febrile neutropenia. According to multivariate analysis, lung infection (HR3.6, p 0.027) and fever before hemotherapy (HR3.5, p 0.049) were predictive factors associated with in-hospital death. A 30-day survival rate was 78.4%.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

Adult AML patient, newly diagnosis
age > 15 y
plan high intensive chemotherapy

Exclusion Criteria

death before start chemotherapy
change plan to palliative or low dose treatment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
death 30 day death after chemotherapy at 30 day,predictive factors associated with death 30 days 30 day mortality
Secondary Outcome Measures
NameTimeMethod
induction death rate 30 day death/survive at 30 days after chemotherapy,survival rate 30 day patient who survive at 30 day after chemotherapy,complete remission rate after discharge from induction chemotherapy session number of patients with complete remission evaluate after complete treatment
© Copyright 2025. All Rights Reserved by MedPath